Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model

Background and Objectives Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the time of Cytoreductive Surgery (CRS) is an actively researched treatment in patients with advanced ovarian cancer. Relative contribution of heat and chemotherapeutic agents during HIPEC as well as efficacy of a new age...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of surgical oncology 2016-03, Vol.113 (4), p.438-442
Hauptverfasser:	Bespalov, Vladimir G., Kireeva, Galina S., Belyaeva, Olesya A., Kalinin, Oleksiy E., Senchik, Konstantin Y., Stukov, Alexandr N., Gafton, Georgy I., Guseynov, Konstantin D., Belyaev, Alexey M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Agents, Alkylating - administration & dosage Chemotherapy, Cancer, Regional Perfusion - methods cisplatin Cisplatin - administration & dosage Combined Modality Therapy dioxadet Disease Models, Animal Female Hyperthermia, Induced - methods hyperthermic intraperitoneal chemoperfusion (HIPEC) Infusions, Parenteral Ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - therapy peritoneal carcinomatosis Random Allocation Rats Triazines - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!